Postmarketing surveillance of prescription drugs.
Washington, D.C. : Congress of the United States, Office of Technology Assessment : 
United States. /
Food and Drug Administration.
Health Policy > Health Policy / United States.
Drug Evaluation > Drug Evaluation / United States > Drug Evaluation / United States / Legislation.
Drug Evaluation > Drug Evaluation / methods.
Drugs > Drugs / Side effects.
Drugs > Drugs / Testing.
Drugs > Drugs / United States. > Drugs / United States. / Quality control.
ix, 70 p. :
|Locate a Print Version:||
Find in a library
|Item Link||Original Source|
|Full view||University of California|
|Full view||University of Minnesota|